Advertisement
Screener

ASTROTECH Corp (ASTC) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

2.0 / 5 stars · 32/79 Roast Me

ASTROTECH Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

ASTROTECH Corp (ASTC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 78.25 million shares for the 9-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-06.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06

  • ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 15.50M shares, a 0.65% increase year-over-year.
  • ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
  • ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 62.75M shares, a 5.23% decline year-over-year.
  • ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 15.65M shares, a 37.28% increase year-over-year.
  • ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 102.26M shares, a 22.44% decline from fiscal 2024.
  • ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 131.84M shares, a 1793.71% increase from fiscal 2023.
  • ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 6.96M shares, a 76.16% decline from fiscal 2022.
  • ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 29.20M shares, a 58300.00% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed
2026-03-3115.50M shares
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-08-06
15.50M shares
derived: sum of 2 quarters · filed 2026-08-06
78.25M shares
10-Q/A · filed 2026-08-06
93.90M shares
derived: sum of 4 quarters · filed 2026-08-06
2025-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13
62.75M shares
10-Q · filed 2026-02-13
78.40M shares
derived: sum of 3 quarters · filed 2026-02-13
93.80M shares
derived: sum of 4 quarters · filed 2026-02-13
2025-09-3062.75M shares
10-Q · filed 2025-11-13
78.40M shares
derived: sum of 2 quarters · filed 2025-11-13
93.80M shares
derived: sum of 3 quarters · filed 2025-11-13
98.80M shares
derived: sum of 4 quarters · filed 2025-11-13
2025-06-3015.65M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26
31.05M shares
derived: sum of 2 quarters · filed 2025-09-26
36.05M shares
derived: sum of 3 quarters · filed 2025-09-26
102.26M shares
10-K · filed 2025-09-26
2025-03-3115.40M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14
20.40M shares
derived: sum of 2 quarters · filed 2025-05-14
86.61M shares
10-Q · filed 2025-05-14
98.01M shares
derived: sum of 4 quarters · filed 2025-09-26
2024-12-315.00M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14
71.21M shares
10-Q · filed 2025-02-14
82.61M shares
derived: sum of 3 quarters · filed 2025-09-26
86.26M shares
derived: sum of 4 quarters · filed 2025-09-26
2024-09-3066.21M shares
10-Q · filed 2024-11-13
77.61M shares
derived: sum of 2 quarters · filed 2025-09-26
81.26M shares
derived: sum of 3 quarters · filed 2025-09-26
81.26M shares
derived: sum of 4 quarters · filed 2025-09-26
2024-06-3011.40M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26
15.05M shares
derived: sum of 2 quarters · filed 2025-09-26
15.05M shares
derived: sum of 3 quarters · filed 2025-09-26
131.84M shares
10-K · filed 2025-09-26
2024-03-313.65M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14
3.65M shares
derived: sum of 2 quarters · filed 2024-05-14
120.44M shares
10-Q · filed 2024-05-14
127.40M shares
derived: sum of 4 quarters · filed 2024-09-20
2023-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13
116.79M shares
10-Q · filed 2024-02-13
123.75M shares
derived: sum of 3 quarters · filed 2024-09-20
123.75M shares
derived: sum of 4 quarters · filed 2024-09-20
2023-09-30116.79M shares
10-Q · filed 2023-11-13
123.75M shares
derived: sum of 2 quarters · filed 2024-09-20
123.75M shares
derived: sum of 3 quarters · filed 2024-09-20
123.60M shares
derived: sum of 4 quarters · filed 2024-09-20
2023-06-306.96M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20
6.96M shares
derived: sum of 2 quarters · filed 2024-09-20
6.81M shares
derived: sum of 3 quarters · filed 2024-09-20
6.96M shares
10-K · filed 2024-09-20
2023-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12
-149.84K shares
derived: sum of 2 quarters · filed 2023-05-12
5.16K shares
10-Q · filed 2023-05-12
29.21M shares
derived: sum of 4 quarters · filed 2023-09-28
2022-12-31-149.84K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-13
5.16K shares
10-Q · filed 2023-02-13
29.21M shares
derived: sum of 3 quarters · filed 2023-09-28
2022-09-30155.00K shares
10-Q · filed 2022-11-14
29.36M shares
derived: sum of 2 quarters · filed 2023-09-28
2022-06-3029.20M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28
29.20M shares
10-K · filed 2023-09-28
876.00K shares
10-K · filed 2022-09-15
2022-03-310.00 shares
10-Q · filed 2022-05-13
2021-06-300.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-15
50.00K shares
derived: sum of 2 quarters · filed 2022-09-15
50.00K shares
derived: sum of 3 quarters · filed 2022-09-15
50.00K shares
10-K · filed 2022-09-15
2021-03-3150.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14
50.00K shares
derived: sum of 2 quarters · filed 2021-05-14
50.00K shares
10-Q · filed 2021-05-14
50.00K shares
derived: sum of 4 quarters · filed 2021-09-21
2020-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16
0.00 shares
10-Q · filed 2021-02-16
0.00 shares
derived: sum of 3 quarters · filed 2021-09-21
0.00 shares
derived: sum of 4 quarters · filed 2021-09-21
2020-09-300.00 shares
10-Q · filed 2020-11-13
0.00 shares
derived: sum of 2 quarters · filed 2021-09-21
0.00 shares
derived: sum of 3 quarters · filed 2021-09-21
10.00K shares
derived: sum of 4 quarters · filed 2021-09-21
2020-06-300.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-21
0.00 shares
derived: sum of 2 quarters · filed 2021-09-21
10.00K shares
derived: sum of 3 quarters · filed 2021-09-21
10.00K shares
10-K · filed 2021-09-21
2020-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-14
10.00K shares
derived: sum of 2 quarters · filed 2020-05-14
10.00K shares
10-Q · filed 2020-05-14
2019-12-3110.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14
10.00K shares
10-Q · filed 2020-02-14
2019-09-300.00 shares
10-Q · filed 2019-11-14
2019-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-13
0.00 shares
derived: sum of 2 quarters · filed 2019-05-13
0.00 shares
10-Q · filed 2019-05-13
2018-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-12
0.00 shares
10-Q · filed 2019-02-12
2018-09-300.00 shares
10-Q · filed 2018-11-14
2018-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15
0.00 shares
derived: sum of 2 quarters · filed 2018-05-15
0.00 shares
10-Q · filed 2018-05-15
-219.81M shares
derived: sum of 4 quarters · filed 2018-09-25
2017-12-310.00 shares
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-02-12
0.00 shares
10-Q · filed 2018-02-12
-219.81M shares
derived: sum of 3 quarters · filed 2018-09-25
-219.81M shares
derived: sum of 4 quarters · filed 2018-09-25
2017-09-300.00 shares
10-Q/A · filed 2018-02-12
-219.81M shares
derived: sum of 2 quarters · filed 2018-09-25
-219.81M shares
derived: sum of 3 quarters · filed 2018-09-25
-219.81M shares
derived: sum of 4 quarters · filed 2018-09-25
2017-06-30-219.81M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-25
-219.81M shares
derived: sum of 2 quarters · filed 2018-09-25
-219.81M shares
derived: sum of 3 quarters · filed 2018-09-25
185.00K shares
10-K · filed 2018-09-25
2017-03-310.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-09
0.00 shares
derived: sum of 2 quarters · filed 2017-05-09
220.00M shares
10-Q · filed 2017-05-09
2016-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-13
220.00M shares
10-Q · filed 2017-02-13
2016-09-30220.00M shares
10-Q · filed 2016-11-14
2016-03-31170.00M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11
170.00M shares
derived: sum of 2 quarters · filed 2016-05-11
170.00M shares
10-Q · filed 2016-05-11
2015-12-310.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-10
0.00 shares
10-Q · filed 2016-02-10
2015-09-300.00 shares
10-Q · filed 2015-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Precipio, Inc. (PRPO)United States$0.043B-36.70
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15